Agnew-Blais, JC, Polanczyk, GV, Danese, A, Wertz, J, Moffitt, TE, Arseneault, L (2016). Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA Psychiatry 73, 713–720.
Bai, M, Lazenby, M (2015). A systematic review of associations between spiritual well-being and quality of life at the scale and factor levels in studies among patients with cancer. Journal of Palliative Medicine 18, 286–298.
Banaschewski, T, Gerlach, M, Becker, K, Holtmann, M, Döpfner, M, Romanos, M (2016). Trust, but verify. The errors and misinterpretations in the Cochrane analysis by O. J. Storebo and colleagues on the efficacy and safety of methylphenidate for the treatment of children and adolescents with ADHD. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 44, 307–314.
Baroni, A, Castellanos, FX (2015). Neuroanatomic and cognitive abnormalities in attention-deficit/hyperactivity disorder in the era of ‘high definition’ neuroimaging. Current Opinion in Neurobiology 30, 1–8.
Button, KS, Ioannidis, JPA, Mokrysz, C, Nosek, BA, Flint, J, Robinson, ESJ, Munafò, MR (2013). Power failure: why small sample size undermines the reliability of neuroscience. Nature Reviews Neuroscience 14, 365–376.
Castellanos, FX, Proal, E (2012). Large-scale brain systems in ADHD: beyond the prefrontal-striatal model. Trends in Cognitive Sciences 16, 17–26.
Conrad, P, Bergey, MR (2014). The impending globalization of ADHD: notes on the expansion and growth of a medicalized disorder. Social Science & Medicine 122, 31–43.
Crosbie, J, Arnold, P, Paterson, A, Swanson, J, Dupuis, A, Li, X, Shan, J, Goodale, T, Tam, C, Strug, LJ, Schachar, RJ (2013). Response inhibition and ADHD traits: correlates and heritability in a community sample. Journal of Abnormal Child Psychology 41, 497–507.
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. The Lancet 381, 1371–1379.
Danckaerts, M, Sonuga-Barke, EJS, Banaschewski, T, Buitelaar, J, Döpfner, M, Hollis, C, Santosh, P, Rothenberger, A, Sergeant, J, Steinhausen, H-C, Taylor, E, Zuddas, A, Coghill, D (2009). The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. European Child & Adolescent Psychiatry 19, 83–105.
Doyle, AE (2015). Commentary: insights from across diagnostic boundaries: ADHD in the RDoC era – a commentary on Scerif and Baker (2015). Journal of Child Psychology and Psychiatry 56, 274–277.
Foreman, DM (2010). The impact of governmental guidance on the time taken to receive medication for ADHD in England. Child and Adolescent Mental Health 15, 12–17.
Foreman, DM, Dack, S, Ford, T (2008). Assessing the diagnostic accuracy of the identification of hyperkinetic disorders following the introduction of government guidelines in England. Child and Adolescent Psychiatry and Mental Health 2, 1–7. https://doi.org/10.1186/1753-2000-2-32
Foreman, DM, Morton, S, Ford, T (2009). Exploring the clinical utility of the Development And Well-Being Assessment (DAWBA) in the detection of hyperkinetic disorders and associated diagnoses in clinical practice. Journal of Child Psychology and Psychiatry 50, 460–470.
Frodl, T, Skokauskas, N (2012). Meta‐analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatrica Scandinavica 125, 114–126.
Gambrill, E (2014). The Diagnostic and Statistical Manual of Mental Disorders as a major form of dehumanization in the modern world. Research on Social Work Practice 24, 13–36.
Goodman, R, Ford, T, Richards, H, Gatward, R, Meltzer, H (2000). The Development and Well-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology. Journal of Child Psychology & Psychiatry & Allied Disciplines 41, 645–655.
Greenhalgh, J (2009). The applications of PROs in clinical practice: what are they, do they work, and why? Quality of Life Research 18, 115–123.
Greven, CU, Merwood, A, Meer, JM, Haworth, C, Rommelse, N, Buitelaar, JK (2016). The opposite end of the attention deficit hyperactivity disorder continuum: genetic and environmental aetiologies of extremely low ADHD traits. Journal of Child Psychology and Psychiatry 57, 523–531.
Groom, MJ, Young, Z, Hall, CL, Gillott, A, Hollis, C (2016). The incremental validity of a computerised assessment added to clinical rating scales to differentiate adult ADHD from autism spectrum disorder. Psychiatry Research 243, 168–173.
Hall, CL, Valentine, AZ, Groom, MJ, Walker, GM, Sayal, K, Daley, D, Hollis, C (2015). The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review. European Child & Adolescent Psychiatry 25, 677–699.
Hall, CL, Walker, GM, Valentine, AZ, Guo, B, Kaylor-Hughes, C, James, M, Daley, D, Sayal, K, Hollis, C (2014). Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD—‘Assessing QbTest Utility in ADHD’(AQUA): a randomised controlled trial. BMJ Open 4, e006838.
Hart, H, Radua, J, Nakao, T, Mataix-Cols, D, Rubia, K (2013). Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 70, 185–198.
Hiscock, H, Sciberras, E, Mensah, F, Gerner, B, Efron, D, Khano, S, Oberklaid, F (2015). Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial. BMJ 350, h68.
Jensen, PS, Arnold, LE, Richters, JE, Severe, JB, Vereen, D, Schiller, E, Hinshaw, SP, Elliou, GR, Conners, CK, Wells, KC, Swanson, JM, Wigal, T, Cantwell, DP, Abikoff, HB, Hechtman, L, Newcorn, JH (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity ‘strong’ disorder. Archives of General Psychiatry 56, 1073–1086.
Kooij, SJJ, Bejerot, S, Blackwell, A, Caci, H, Casas-Brugué, M, Carpentier, PJ, Edvinsson, D, Fayyad, J, Foeken, K, Fitzgerald, M (2010). European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 10, 67.
Kordon, A, Stollhoff, K, Niederkirchner, K, Mattejat, F, Rettig, K, Schäuble, B (2011). Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH. Postgraduate Medicine 123, 27–38.
Leo, J, Cohen, D (2009). A critical review of ADHD neuroimaging research. In Rethinking ADHD: From Brain to Culture (ed. S. Timimi and J. Leo), pp. 92–129. Palgrave Macmillan: England.
Lindstrøm, JA (2012). Why attention-deficit/hyperactivity disorder is not a true medical syndrome. Ethical Human Psychology and Psychiatry 14, 61–73.
Menon, V (2015). Salience network. In Brain Mapping: An Encyclopedic Reference, vol. 2 (ed. A. W. Toga), pp. 597–611. Academic Press: Elsevier.
Middeldorp, CM, Hammerschlag, AR, Ouwens, KG, Groen-Blokhuis, MM St., Pourcain, B, Greven, CU, Pappa, I, Tiesler, CMT, Ang, W, Nolte, IM, Vilor-Tejedor, N, Bacelis, J, Ebejer, JL, Zhao, H, Davies, GE, Ehli, EA, Evans, DM, Fedko, IO, Guxens, M, Hottenga, J-J, Hudziak, JJ, Jugessur, A, Kemp, JP, Krapohl, E, Martin, NG, Murcia, M, Myhre, R, Ormel, J, Ring, SM, Standl, M, Stergiakouli, E, Stoltenberg, C, Thiering, E, Timpson, NJ, Trzaskowski, M, van der Most, PJ, Wang, C, Nyholt, DR, Medland, SE, Neale, B, Jacobsson, B, Sunyer, J, Hartman, CA, Whitehouse, AJO, Pennell, CE, Heinrich, J, Plomin, R, Smith, GD, Tiemeier, H, Posthuma, D, Boomsma, DI (2016). A genome-wide association meta-analysis of attention-deficit/hyperactivity disorder symptoms in population-based paediatric cohorts. Journal of the American Academy of Child & Adolescent Psychiatry 55, 896–905.e6.
Moffitt, TE, Houts, R, Asherson, P, Belsky, DW, Corcoran, DL, Hammerle, M, Harrington, H, Hogan, S, Meier, MH, Polanczyk, GV, Poulton, R, Ramrakha, S, Sugden, K, Williams, B, Rohde, LA, Caspi, A (2015). Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. American Journal of Psychiatry 172, 967–977.
Moncrieff, J, Timimi, S (2013). The social and cultural construction of psychiatric knowledge: an analysis of NICE guidelines on depression and ADHD. Anthropology & Medicine 20, 59–71.
Phillips, CB (2006). Medicine goes to school: teachers as sickness brokers for ADHD. PLOS Medicine 3, e182.
Polanczyk, GV, Willcutt, EG, Salum, GA, Kieling, C, Rohde, LA (2014). ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. International Journal of Epidemiology 43, 434–442.
Quinn, M, Lynch, A (2016). Is ADHD a ‘real’ disorder? Support for Learning 31, 59–70.
Rapport, MD, Orban, SA, Kofler, MJ, Friedman, LM (2013). Do programs designed to train working memory, other executive functions, and attention benefit children with ADHD? A meta-analytic review of cognitive, academic, and behavioral outcomes. Clinical Psychology Review 33, 1237–1252.
Rentz, AM, Matza, LS, Secnik, K, Swensen, A, Revicki, DA (2004). Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder. Quality of Life Research 14, 719–734.
Rosales, AG, Vitoratou, S, Banaschewski, T, Asherson, P, Buitelaar, J, Oades, RD, Rothenberger, A, Steinhausen, H-C, Faraone, SV, Chen, W (2015). Are all the 18 DSM-IV and DSM-5 criteria equally useful for diagnosing ADHD and predicting comorbid conduct problems? European Child & Adolescent Psychiatry 24, 1325–1337.
Rubio, B, Boes, AD, Laganiere, S, Rotenberg, A, Jeurissen, D, Pascual-Leone, A (2016). Noninvasive brain stimulation in pediatric attention-deficit hyperactivity disorder (ADHD): a review. Journal of Child Neurology 31, 784–796.
Sacks, O (1992). Tourette’s syndrome and creativity. BMJ: British Medical Journal 305, 1515.
Sonuga-Barke, EJS, Brandeis, D, Cortese, S, Daley, D, Ferrin, M, Holtmann, M, Stevenson, J, Danckaerts, M, van der Oord, S, Döpfner, M, Dittmann, RW, Simonoff, E, Zuddas, A, Banaschewski, T, Buitelaar, J, Coghill, D, Hollis, C, Konofal, E, Lecendreux, M, Wong, ICK, Sergeant, J (2013). Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry 170, 275–289.
Storebø, OJ, Ramstad, E, Krogh, HB, Nilausen, TD, Skoog, M, Holmskov, M, Rosendal, S, Groth, C, Magnusson, FL, Moreira-Maia, CR, Gillies, D, Buch Rasmussen, K, Gauci, D, Zwi, M, Kirubakaran, R, Forsbøl, B, Simonsen, E, Gluud, C (2015). Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews issue 11, CD009885.
Taylor, D (1979). The components of sickness: diseases, illnesses, and predicaments. The Lancet 314, 1008–1010.
Thagaard, MS, Faraone, SV, Sonuga-Barke, EJ, Østergaard, SD (2016). Empirical tests of natural selection-based evolutionary accounts of ADHD: a systematic review. Acta Neuropsychiatrica 28, 249–256.
Timimi, S, Leo, J (2008). Rethinking ADHD: From Brain to Culture. Palgrave Macmillan: Basingstoke.
Vogt, C, Shameli, A (2011). Assessments for attention-deficit hyperactivity disorder: use of objective measurements. The Psychiatrist Online 35, 380–383.
Vysniauske, R, Verburgh, L, Oosterlaan, J, Molendijk, ML (2016). The effects of physical exercise on functional outcomes in the treatment of ADHD a meta-analysis. Journal of Attention Disorders, https://doi.org/10.1177/1087054715627489
Williams, NM, Zaharieva, I, Martin, A, Langley, K, Mantripragada, K, Fossdal, R, Stefansson, H, Stefansson, K, Magnusson, P, Gudmundsson, OO, Gustafsson, O, Holmans, P, Owen, MJ, O’Donovan, M, Thapar, A (2010). Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. The Lancet 376, 1401–1408.